GoodRx Holdings (GDRX) R&D US GAAP (year values)

2020 2021 2022 2022 2023   LTM ? CAGR 5 years ?
R&D, bln rub 61.8 125.9 143.1 143.1 135.8   123.5  
Changes by years, y/y, % +111% +104% +14% 0% -5%     +25.3%

GoodRx Holdings. R&D, bln rub

GoodRx Holdings. R&D, changes, %

GoodRx Holdings. R&D, sum by quarters, bln rub

GoodRx Holdings (GDRX) R&D US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
R&D, bln rub 39.6 31.5 31.0 30.9 30.1   123.5
Changes by years, y/y, % +10% -14% -6% -1% -24%    
Changes by quarters, q/q, % +27% -20% -2% -1% -2%    

GoodRx Holdings. R&D, bln rub

GoodRx Holdings. R&D, changes, y/y, %

GoodRx Holdings. R&D, changes, q/q, %